Tonix Pharmaceuticals Holding (TNXP) Cost of Revenue (2023 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Cost of Revenue of $703,000 for Q2 2026, down 78.5% from $3.27 million a year earlier and down 55.4% from the prior quarter.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Cost of Revenue (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Tonix Pharmaceuticals Holding was $4.71 million, down 32.3% year-over-year; for FY2025, it was $6.64 million, down 14.5% from FY2024.
- In prior years, Tonix Pharmaceuticals Holding's Cost of Revenue was $7.77 million in FY2024 (+63.8%) and $4.74 million in FY2023.
- The Q2 2026 figure stands as the lowest quarterly Cost of Revenue in data going back to Q3 2023.
- On a year-over-year basis, Cost of Revenue increased in 1 of the last eight quarters, with an average decline of 20.5%.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was Q1 2026, with growth of 67.3%; the weakest was Q2 2026, with a decline of 78.5%.
- According to Business Quant data, Cost of Revenue for the three prior quarters was $1.58 million (Q1 2026), $1.06 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Tonix Pharmaceuticals Holding | 86.82 Mn | -672.58 Mn | 12.84 Mn | 703,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 703,000.00 |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 3.27 Mn |
| Mar 31, 2025 | 943,000.00 |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Mar 31, 2024 | 1.66 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.37 Mn |
API Access
Tonix Pharmaceuticals Holding Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TNXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TNXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TNXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();